Skip to main content
University of Maryland 1856

Home

  • Twitter
  • About Us
    • NDEWS Overview
    • People
  • Drugs
    • Drug Information
    • Drug Outbreak Testing Service (DOTS)
    • New Psychoactive Substance (NPS)
    • Toxicology Case Studies - ACMT
    • NDEWS News Scans
    • Social Media Data Mining
  • Project Publications
    • Publications
    • HotSpot Reports
  • Sentinel Sites
    • Sentinel Sites: Reports and Epidemiologists
    • Cross-Site Data Presentation
  • Resources
    • NDEWS Presents Webinars
    • Community Drug Early Warning System (CDEWS)
    • Drug Surveillance Systems in Other Countries
    • National and State Data Sources
    • Supervised Injection Research and Policy
    • Outside Publications
    • Conferences and Meetings
  • Data
  • About Us
    • NDEWS Overview
    • People
  • Drugs
    • Drug Information
    • Drug Outbreak Testing Service (DOTS)
    • New Psychoactive Substance (NPS)
    • Toxicology Case Studies - ACMT
    • NDEWS News Scans
    • Social Media Data Mining
  • Project Publications
    • Publications
    • HotSpot Reports
  • Sentinel Sites
    • Sentinel Sites: Reports and Epidemiologists
    • Cross-Site Data Presentation
  • Resources
    • NDEWS Presents Webinars
    • Community Drug Early Warning System (CDEWS)
    • Drug Surveillance Systems in Other Countries
    • National and State Data Sources
    • Supervised Injection Research and Policy
    • Outside Publications
    • Conferences and Meetings
  • Data
Enter the terms you wish to search for.

Publications

  • DOTS Issue 7 - Methamphetamine, but No Fentanyl, Found in Opiate-Positive Specimens from a Corpus Christi, Texas, Residential Treatment Center; Multiple Drugs Found in Every Specimen dotsbulletin-issue7-august2018-charliesplacetx-final_0.pdf299.55 KB
  • DOTS Issue 5 - Uninsured Opioid Users Admitted to Medication-Assisted Treatment (MAT) Program in Palm Beach County, Florida, Found to Be Using Many Drugs in Addition to Opioids dots-bulletin-issue5-july2018-palmbeach-mat-final_0.pdf159.28 KB
  • DOTS Issue 6 - No Fentanyl Analogs but Buprenorphine, Naloxone, and Marijuana Detected in Specimens from Suspected Users of Fentanyl in Vermont dotsbulletin-issue6-july2018-aspenti-final_0.pdf121.62 KB
  • DOTS Issue 1 - Overview of the Drug Outbreak Testing Service Pilot Study dotsbulletin-issue1-june2018-methodology-final_0.pdf97.59 KB
  • DOTS Issue 2 - First DOTS Study Finds Fentanyl and Polydrug Use in Patients Seen During Opioid Overdose Spike in Baltimore – Higher Doses of Naloxone May Be Needed dotsbulletin-issue2-june2018-baltimore-midtown-final_0.pdf160.4 KB
  • DOTS Issue 3 - Methamphetamine, Opioids, Cocaine, and Multiple Drugs Were Most Common in Specimens from Seattle/King County Area Decedents dotsbulletin-issue3-june2018-kingcomedicalex-final_0.pdf190.22 KB
  • DOTS Issue 4 - Drug-Positive Urine Specimens from Uninsured or Publicly Insured Residents of Montgomery County, Maryland, Contain No Fentanyl and Few Synthetic Cannabinoids but Do Contain Multiple Drugs dotsbulletin-issue4-june2018-accesstobh-final_0.pdf128.54 KB
  • Abbate, V., Schwenk, M., Presley, B.C., & Uchiyama, N. (2018). The ongoing challenge of novel psychoactive drugs of abuse: Part I. Synthetic cannabinoids (IUPAC Technical Report). Pure and Applied Chemistry, published online ahead of print.
  • Abrams, D.B., Glasser, A.M., Pearson, J.L., Villanti, A.C., Collins, L.K., & Niaura, R.S. (2018). Harm Minimization and Tobacco Control: Reframing Societal Views of Nicotine Use to Rapidly Save Lives. Annual Review of Public Health, 39: 193-213.
  • Ahmad, F.B., Rossen, L.M., Spencer, M.R., Warner, M., & Sutton, P. (2018). Provisional drug overdose death counts. National Center for Health Statistics.
  • Artigiani, E.E., Hsu, M.H., McCandlish, D., and Wish, E.D. (2018). Methamphetamine: A Regional Drug Crisis. College Park, MD: National Drug Early Warning System. ndews-scs-methamphetamine-report-september-2018-final.pdf1.16 MB
  • Buchanich, J.M., Balmert, L.C., Williams, K.E., & Burke, D.S. (2018). The Effect of Incomplete Death Certificates on Estimates of Unintentional Opioid-Related Overdose Deaths in the United States, 1999-2015. Public Health Reports, XX(X), 1-9.
  • Cramer, M. (2018). State’s highest court rules that judges may force defendants with drug addiction to stay sober. Boston Globe. Boston, Massachusetts.
  • Drug Enforcement Administration. (2018). Slang Terms and Code Words: A Reference for Law Enforcement Personnel. Intelligence Report. dea-drug-slang-terms-and-code-words-july2018.pdf1.35 MB
  • European Monitoring Centre for Drugs and Drug Addiction. (2018). 2018 European Drug Report.
  • European Monitoring Centre for Drugs and Drug Addiction. (2018). Fentanils and synthetic cannabinoids: driving greater complexity into the drug situation — an update from the EU Early Warning System.
  • Florida Department of Law Enforcement. (2018). Drugs Identified in Deceased Persons by Florida Medical Examiners - 2017 Interim Report.
  • Governmnent Accountability Office. (2018). Illicit Opioids: Office of National Drug Control Policy and Other Agencies Need to Better Assess Strategic Efforts. Testimony Before the Committee on Oversight and Government Reform, House of Representatives.
  • Green, T.C., Clarke, J., & Brinkley-Rubinstein, L. (2018). Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System. JAMA Psychiatry, 75(4): 405-7.
  • Janakiram, C., Chalmers, N.I., Fontelo, P., Huser, V., Lopez-Mitnick, G., Iafolla, T.J., Brow, A.R., Dye, B.A. (2018). Sex and race or ethnicity disparities in opioid prescriptions for dental diagnoses among patients receiving Medicaid. Journal of the American Dental Association, 149(4): 246-55.
  • Jones C.M., Einstein E.B., & Compton W.M. (2018). Changes in Synthetic Opioid Involvement in Drug Overdose Deaths in the United States, 2010-2016. JAMA., 319(17):1819–21.
  • Kann, L., McManus, T., Harris, W.A., et al. Youth Risk Behavior Surveillance — United States, 2017. MMWR Surveillance Summaries, 67(No. SS-8):1–114
  • Krotulski, A.J., Mohr, A.L.A, Friscia, M., & Logan, B.K. (2018). Monitoring Changes in the Novel Psychoactive Substance (NPS) Market through Enhanced Identification of Emerging Drugs and their Metabolites in Biological Samples. National Criminal Justice Reference Service.
  • Lamy, F., Daniulaityte, R., Sheth, A., et al. (2018). eDark Trends update: New synthetic opioids, MPF-47,700, U-4TDP, U-48,800, U-49,900, and U-50,488 identified on two cryptomarkets. Wright State University. edarktrends_information_letter_1.pdf587.56 KB
  • National Academies of Sciences, Engineering, and Medicine. (2018). Public Health Consequences of E-Cigarettes. Washington, DC: The National Academies Press.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Next page Next ›
  • Last page Last »

Center for Substance Abuse Research
University of Maryland
4321 Hartwick Rd, Ste 501, College Park, MD 20740
Phone: 301-405-9794 ♦ Fax: 301-403-8342
Email: ndews [at] umd.edu ♦ Contact Us ♦ Join Listserv
Disclaimers ♦ Privacy Policy

  • Join the NDEWS Network
  • College Directory
  • Alumni Association
  • UMD Web Accessibility
University of Maryland 1856 - College of Behavioral & Social Sciences

Login / Logout